prion
diseas
group
fatal
neurodegen
disord
associ
conform
convers
cellular
prion
protein
prpc
mainli
beta
sheet
form
prpsc
mechan
prpc
convert
abnorm
isoform
still
clear
presum
involv
complex
latter
serv
conform
templat
model
prpsc
serv
templat
bind
prpc
produc
conform
convers
abnorm
isoform
rais
issu
whether
critic
contact
site
mediat
convers
case
interf
block
complex
format
prevent
prpc
prpsc
convers
process
previou
report
describ
antiprp
antibodi
stop
hinder
convers
process
add
refer
renumb
protein
misfold
cyclic
amplif
pmca
assay
mimic
prpsc
propag
process
cellfre
condit
method
prpsc
amplifi
convert
prpc
prpsc
seed
incub
period
sonic
prpsc
gener
pmca
infecti
wildtyp
anim
indefinit
propag
preserv
properti
origin
prpsc
strain
furthermor
pmca
quit
use
studi
cofactor
influenc
prp
convers
detect
prpsc
biolog
sampl
human
anim
hypothes
antibodi
bind
prpc
andor
prpsc
might
hinder
prevent
format
complex
thu
prevent
convers
process
compar
effect
individu
prpspecif
monoclon
antibodi
mab
convers
process
use
cell
cultur
model
testtub
pmca
system
result
demonstr
mab
rang
inhibitori
effect
convers
process
degre
inhibit
mab
specif
depend
antibodi
target
region
specif
epitop
recogn
furthermor
sinc
pmcabas
method
dosedepend
rapid
may
serv
ideal
screen
assay
potenti
inhibitor
prpsc
accumul
progress
prion
diseas
procedur
involv
anim
care
conduct
accord
unit
state
depart
agricultur
anim
welfar
act
nation
institut
health
polici
human
care
use
laboratori
anim
tissu
sampl
uninfect
prion
agentinfect
mice
hamster
obtain
use
protocol
approv
institut
anim
care
use
committe
suni
downstat
medic
center
protocol
normal
hamster
brain
homogen
nbh
prepar
phosphat
buffer
salin
pb
contain
triton
edta
proteas
inhibitor
cocktail
abcam
prpspecif
mab
gener
recombin
murin
hamster
prp
brainderiv
proteinas
k
pk
resist
purifi
prpsc
brain
clinic
mice
infect
mouseadapt
scrapi
strain
clinic
hamster
infect
hamsteradapt
scrapi
strain
mab
use
studi
purifi
montag
antibodi
purif
kit
millipor
billerica
ca
isotyp
elisa
mous
antibodi
isotyp
kit
thermo
fisher
rockford
il
epitop
map
tabl
immunoreact
mab
analyz
western
blot
denatur
pkdigest
undigest
prp
deriv
uninfect
infect
brain
homogen
well
elisa
recombin
prp
except
mab
individu
mab
equival
immunoreact
murin
hamster
prpsc
immunoglobulin
concentr
basi
mab
highli
reactiv
hamster
prpc
prpsc
isoform
pmca
studi
individu
ad
nbh
final
concentr
brain
homogen
prepar
pb
dilut
final
concentr
aliquot
homogen
initi
combin
nbh
without
ad
mab
sampl
sonic
qsonic
power
amplitud
j
energi
sec
process
time
sec
puls
sec
puls
incub
hr
defin
one
cycl
serial
pmca
spmca
complet
cycl
addit
nbh
without
mab
ad
end
everi
five
cycl
total
volum
transfer
new
tube
contain
equal
volum
nbh
without
mab
cycl
reaction
continu
complet
cycl
sampl
pktreat
final
concentr
min
follow
addit
proteas
inhibitor
cocktail
sampl
heat
min
centrifug
min
room
temperatur
supernat
combin
laemmli
sampl
buffer
electrophores
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
follow
transfer
nitrocellulos
membran
membran
block
hr
pb
contain
tween
pbst
nonfat
dri
milk
incub
biotinyl
mab
membran
wash
time
min
pbst
incub
min
hrpconjug
streptavidin
invitrogen
pbst
contain
nonfat
dri
milk
follow
addit
pbst
wash
detect
protein
ecl
supersign
west
dura
kit
thermo
fisher
quantif
prpsc
perform
densitometr
analysi
use
nih
imag
j
softwar
cellulos
membran
spot
overlap
prp
peptid
produc
previous
describ
membran
block
nonfat
dri
milktrisbuff
salin
contain
tween
tbst
probe
antibodi
dilut
normal
goat
serumtb
overnight
follow
horseradish
peroxidas
hrp
conjug
goat
antimous
secondari
cappel
hour
room
temperatur
detect
use
millipor
immobilon
western
chemiluminesc
hrp
substrat
cat
membran
regener
reus
shake
dimethylformamid
minut
trishcl
ph
sd
overnight
follow
min
wash
buffer
twice
minut
methanolglaci
acet
acid
final
three
time
minut
methanol
air
dri
membran
store
seal
contain
room
temperatur
murin
neuroblastoma
cell
atcc
line
ccl
grown
minim
essenti
medium
supplement
fb
penicillin
streptomycin
infect
brain
homogen
describ
previous
follow
infect
amount
prpsc
cell
lysat
aliquot
cell
determin
pk
digest
pk
min
sdspage
tristricin
gel
western
blot
analysi
previous
describ
treatment
cell
mab
cell
fifth
passag
infect
higher
plate
sixwel
plate
cell
confluent
mab
ad
final
concentr
incub
continu
hr
mab
test
three
independ
experi
use
independ
infect
cell
line
experi
includ
posit
control
untreat
cell
neg
control
cell
subject
pk
digest
level
pkresist
prpsc
measur
western
blot
use
hrpconjug
sheep
antimous
igg
secondari
reagent
ecl
supersign
west
dura
kit
membran
expos
xray
film
xomat
blue
kodak
new
ct
constant
exposur
time
sec
film
convert
eightbit
grayscal
digit
file
quantif
prpsc
perform
densitometr
analysi
use
nih
imag
j
softwar
v
area
curv
three
prp
band
repres
non
monoand
diglycosyl
isoform
protein
summar
sampl
calcul
total
amount
prp
express
percentag
averag
valu
posit
control
untreat
wherea
optic
densiti
background
taken
neg
control
lane
cell
prpspecif
mab
evalu
abil
prevent
prpc
prpsc
convers
linear
epitop
span
entir
prion
protein
amino
carboxi
terminu
tabl
fig
use
cell
persist
infect
mouseadapt
scrapi
strain
evalu
affect
mab
prpsc
format
fig
treatment
mab
result
cytotox
cell
throughout
incub
period
incub
cell
purifi
irrelev
mous
igg
effect
prpsc
format
compar
untreat
cultur
fig
mab
reduc
prpsc
format
compar
control
cultur
lack
mab
mab
react
mous
prion
protein
surpris
abil
singli
ad
mab
inhibit
prpsc
format
relat
specif
epitop
sinc
remain
singli
ad
mab
inhibit
prpsc
format
vari
degre
individu
ad
mab
effect
inhibit
prpsc
format
inhibit
least
effect
inhibit
target
amino
terminu
mab
effect
inhibit
prpsc
format
target
octapeptid
repeat
region
use
mab
result
almost
inhibit
strang
although
epitop
overlap
mab
less
effect
mab
inhibit
prpsc
format
vs
inhibit
contrast
mab
overlap
epitop
expans
result
inhibit
respect
combin
result
addit
inhibitori
effect
fact
result
less
inhibit
either
one
alon
confirm
studi
addit
caus
prpsc
inhibit
slightli
better
alon
although
predict
addit
inhibitori
effect
three
mab
combin
plu
combin
observ
studi
perform
pmca
determin
whether
cellfre
system
recapitul
effect
mab
prpc
convers
observ
infect
cell
system
also
allow
us
evalu
whether
access
mab
membran
associ
prpc
live
cell
influenc
prpc
prpsc
convers
process
mab
final
concentr
ad
throughout
protocol
along
nbh
spike
dilut
infect
brain
homogen
describ
method
section
dilut
infect
brain
homogen
result
detect
pk
resist
prpsc
immunostain
fig
therefor
interfer
detect
newli
form
prpsc
complet
sampl
digest
pk
analyz
immunoblot
use
biotinyl
mab
react
equal
hamster
prpc
prpsc
interest
note
although
brain
homogen
display
band
pattern
typic
multipl
glycosyl
form
prpc
prpsc
fig
product
posit
control
mabtreat
reaction
consist
singl
diglycosyl
kda
prpsc
band
observ
pk
digest
higher
level
inhibit
two
band
smear
less
inhibit
fig
pmca
presenc
mab
also
use
studi
import
bind
site
specif
prpc
prpsc
convers
process
fig
perform
spmca
differ
mab
concentr
determin
minimum
amount
mab
necessari
inhibit
convers
process
use
dilut
hamster
brain
homogen
prpsc
seed
normal
brain
homogen
nbh
sourc
prpc
test
abil
mab
inhibit
convers
prpc
prpsc
mab
final
concentr
lane
lane
lane
prepar
hamster
nbh
use
spmca
reaction
compar
contain
mab
lane
except
major
prpspecif
mab
inhibit
convers
process
doserel
manner
although
effect
other
mab
complet
inhibit
convers
process
mab
inhibit
convers
process
lesser
degre
inhibit
caus
mab
specif
respons
sinc
studi
replac
mab
purifi
normal
mous
igg
nbh
caus
inhibit
prpsc
format
data
shown
interest
note
except
epitop
mab
caus
complet
inhibit
locat
amino
half
prp
caus
incomplet
inhibit
locat
carboxi
half
prp
good
correl
extent
prpsc
inhibit
mab
cell
cultur
compar
mab
separ
studi
use
demonstr
mab
caus
complet
inhibit
prpsc
format
fig
therefor
extend
studi
evalu
effect
mab
use
wider
rang
mab
concentr
compar
antibodi
studi
mab
pronounc
effect
prpsc
format
demonstr
low
concentr
respect
caus
complet
inhibit
fig
potent
inhibitori
effect
prpsc
observ
use
coincid
dramat
effect
cultur
model
furthermor
poor
prpsc
inhibit
fig
correspond
well
poor
inhibit
reduct
compar
neg
control
observ
cell
cultur
system
fig
current
effect
treatment
prion
diseas
date
hundr
chemic
compound
identifi
antagon
prion
propag
vitro
cell
culturebas
assay
andor
vivo
anim
studi
unfortun
mani
compound
effici
vitro
studi
effect
anim
model
treatment
begun
close
time
inocul
infecti
agent
furthermor
mani
candid
compound
limit
use
clinic
due
toxic
inabl
cross
bloodbrain
barrier
eg
congo
red
iododoxorubicin
breaker
addit
therapeut
andor
prophylact
strategi
continu
pursu
vaccin
recombin
mous
prp
delay
onset
prion
diseas
mice
passiv
immun
antiprp
antibodi
shown
inhibit
format
prpsc
cellfre
system
also
shown
prevent
infect
suscept
cell
inhibit
prion
replic
infect
cell
effect
treatment
also
depend
administ
rel
time
infect
initi
passiv
immun
studi
use
wildtyp
mice
mab
mous
prp
residu
mous
prp
residu
given
immedi
challeng
scrapi
intraperiton
ip
inject
result
signific
prolong
incub
period
treat
anim
remain
diseas
free
group
challeng
lower
dose
prpsc
anoth
studi
use
higher
antibodi
dose
ip
either
icsm
mous
prp
residu
icsm
mous
residu
prion
infect
peripher
sourc
complet
prevent
treatment
continu
day
immedi
follow
prpsc
challeng
furthermor
transgen
mous
model
express
mab
resist
prion
infect
via
ip
inject
mechan
involv
either
perturb
cellular
prp
traffickingprpc
degrad
disrupt
interact
previou
studi
report
portion
prpc
region
prp
import
gener
prpsc
rigter
et
al
found
two
high
affin
bind
region
proteinprotein
interact
use
ovin
peptidearray
sheepprp
peptid
includ
aminotermin
octarepeat
ii
sheepprp
peptid
encompass
scrapi
susceptibilityassoci
polymorph
sheep
moroncini
et
al
found
residu
within
segment
prpc
key
compon
complex
beringu
et
al
report
antibodi
exclus
bind
prpc
rel
ineffici
inhibitor
prpsc
accumul
compar
antibodi
addit
recogn
diseaseassoci
prp
isoform
et
al
screen
antiprp
mab
capac
inhibit
prpsc
replic
infect
cell
identifi
four
differ
linear
epitop
hinder
prpc
prpsc
convers
amino
termin
region
octarepeat
region
intermedi
region
central
region
observ
antibodi
bind
amino
terminu
prion
protein
capabl
inhibit
convers
suggest
endogen
proteolyt
cleavag
occur
site
convers
complet
explor
possibl
therapeut
effect
antiprp
antibodi
establish
anoth
system
analyz
influenc
ab
convers
process
screen
mab
produc
laboratori
capac
inhibit
prpsc
format
screen
perform
use
cell
cellfre
spmca
cultur
mab
react
mous
prp
reduc
prpsc
format
although
vari
effici
thu
similar
previou
result
found
abil
inhibit
prpc
prpsc
convers
restrict
singl
epitop
limit
specif
region
protein
howev
greatest
inhibit
observ
mab
target
epitop
amino
termin
unstructur
region
prp
greatest
inhibit
cell
mab
consist
prior
studi
use
mab
antiprp
residu
screen
multipl
mab
one
produc
greatest
inhibit
mab
also
shown
efficaci
vivo
prolong
presymptomat
incub
period
mab
inhibit
result
obtain
use
pmca
similar
found
cell
cultur
system
pmca
advantag
cell
cultur
model
costeffect
simpl
rapid
sensit
amen
studi
dose
depend
identif
potenti
candid
mab
might
vivo
activ
like
mab
would
produc
inhibit
much
simpler
vitro
system
interact
prpc
prpsc
critic
depend
structur
compat
molecul
support
exist
speci
barrier
prion
infect
relat
minor
differ
primari
sequenc
prpc
differ
speci
therefor
surpris
antibodi
may
alter
mask
critic
epitop
prpc
andor
prpsc
involv
mutual
conform
complementar
requir
prion
propag
inhibitori
prion
replic
although
mani
antiprp
antibodi
target
differ
region
prp
may
therapeut
effect
vitro
clear
relat
efficaci
vivo
one
hand
tempt
specul
antibodi
exhibit
near
complet
inhibit
vitro
would
effect
vivo
given
obstacl
blood
brain
barrier
access
prp
cell
howev
also
possibl
partial
inhibit
convers
requir
vivo
allow
cell
recov
either
case
would
advantag
therapeut
antibodi
high
affin
bind
prpc
andor
prpsc
well
target
specif
critic
prp
domain
one
hypothes
simultan
target
one
critic
epitop
lead
greater
benefit
howev
cotreat
experi
perform
mixtur
two
antibodi
compat
bind
cellsurfac
prpc
show
benefit
compar
treatment
involv
singl
mab
current
experi
previou
studi
demonstr
synergist
bind
one
antibodi
pair
synergist
bind
inhibitori
mab
ie
reaction
antibodi
increas
bind
second
antibodi
would
predict
enhanc
inhibitori
effect
studi
antibodi
pair
fit
descript
requir
test
hypothesi
addit
determin
signific
mab
abil
bind
prpc
prpsc
may
provid
insight
convers
process
